Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Scheithauer, W.; Mckendrick, J.; Begbie, S.; Borner, M.; Burns, W. I.; Burris, H. A.; Cassidy, J.; Jodrell, D.; Koralewski, P.; Levine, E. L.; Marschner, N.; Maroun, J.; Garcia-Alfonso, P.; Tujakowski, J.; Van Hazel, G.; Wong, A.; Zaluski, J.; Twelves, C. (2003). Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of oncology, 14(12), pp. 1735-1743. Oxford University Press 10.1093/annonc/mdg500

[img]
Preview
Text
mdg500.pdf - Published Version
Available under License Publisher holds Copyright.

Download (118kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Borner, Markus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

27 Sep 2018 15:47

Last Modified:

23 Oct 2019 04:07

Publisher DOI:

10.1093/annonc/mdg500

BORIS DOI:

10.7892/boris.115800

URI:

https://boris.unibe.ch/id/eprint/115800

Actions (login required)

Edit item Edit item
Provide Feedback